Ataxia--its causes, measurement, and management.
This paper reviews the various types of ataxia, and some related clinical manifestations. Methods of measuring normal and abnormal movement are then discussed, followed by a consideration of management and specific and symptomatic treatments.
D000617:Aminoglycosides / Q000009:adverse effects; D000900:Anti-Bacterial Agents / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000009:adverse effects; D001259:Ataxia / Q000139:chemically induced / Q000503:physiopathology* / Q000534:rehabilitation; D002524:Cerebellar Ataxia / Q000503:physiopathology; D006801:Humans; D007980:Levodopa / Q000009:adverse effects; D009068:Movement; D012656:Self-Help Devices
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000927:Anticonvulsants; D014150:Antipsychotic Agents; D007980:Levodopa